Evozyne logo
Evozyne logo

Evozyne

evozyne.com
evozyne.com • HQ: Chicago, United States • Venture - Series Unknown 2023 • 201-500 employees • Founded 2019 • Startup • New
HQ: Chicago, United States • Venture - Series Unknown 2023 • 201-500 employees • Founded 2019 • Startup • New
Actively hiring
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$144.4M
3 rounds on record
Latest round
$81M
Venture round · Sep 2023 · 3 yr ago
Team
201-500
employees, estimated range
Backers
1
OrbiMed
The money's age
Long since its last round
36 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2023 $81M — SEC Form D
Venture round Apr 2021 $54.2M — SEC Form D
Venture round Apr 2020 $9.2M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Evozyne, LLC sec
Founders and leadersfrom filings, registers and the company's site
Aris TheologisExecutive OfficerSEC Form D
Rama RanganathanExecutive Officer, DirectorSEC Form D
Darien ParhadExecutive OfficerSEC Form D
Jeffrey AroninExecutive Officer, DirectorSEC Form D
Patrick MorrisExecutive Officer, DirectorSEC Form D
Jude SullivanExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
OrbiMed fund

Overview

ABOUT US Our Mission To design and build engineered protein therapeutics with our AI-native platform, transforming what's possible in immune-mediated disease treatment. Our Vision To establish AI-designed proteins as a foundational therapeutic modality and bring these novel biologics to patients.

People

Aris Theologis
Executive Officer
SEC Form D
Rama Ranganathan
Executive Officer, Director
SEC Form D
Darien Parhad
Executive Officer
SEC Form D
Jeffrey Aronin
Executive Officer, Director
SEC Form D
Patrick Morris
Executive Officer, Director
SEC Form D
Jude Sullivan
Executive Officer
SEC Form D
Aleina Lee
Executive Officer
SEC Form D
Mike Gamson
Executive Officer, Director
SEC Form D
Arjun Rallapalli
Executive Officer
SEC Form D
Antonio Gracias
Director
SEC Form D
Matthew Rizzo
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Chicago United States
HQ
200-500 est. staff

Financials

Total raised
$144.4M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $81M Details
Venture - Series Unknown 2021 $54.2M Details
Venture - Series Unknown 2020 $9.2M Details